jueves, 27 de noviembre de 2025

MHRA Approves Inavolisib for PIK3CA-Mutated Breast Cancer Zeel Mehta Medscape UK November 27, 2025

https://www.medscape.com/viewarticle/mhra-approves-inavolisib-pik3ca-mutated-breast-cancer-2025a1000x72

No hay comentarios:

Publicar un comentario